{"id":"W4410820333","doi":"10.1200/jco.2025.43.16_suppl.8014","title":"Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Placebo; Chemoradiotherapy; Internal medicine; Oncology; Phases of clinical research; Clinical trial; Cancer; Pathology; Pembrolizumab; Immunotherapy; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052035,0.000237503,0.002459754,0.0001687303,0.00003790138,0.00002318172,0.0003075377,0.000397342,0.0000551735],"category_scores_gemma":[0.006393504,0.0001519225,0.000321433,0.0002271477,0.001262092,0.0000773868,0.0002224395,0.001243274,2.36546e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001327906,"about_ca_system_score_gemma":0.002145072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009901408,"about_ca_topic_score_gemma":0.00026136,"domain_scores_codex":[0.9935713,0.001638309,0.003563199,0.0003541624,0.0005762578,0.0002967289],"domain_scores_gemma":[0.9899393,0.006320523,0.002512607,0.0003836494,0.0005934167,0.0002504928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1452577,0.00285241,0.7646694,0.0004637162,0.0008957631,0.0002462172,0.0004010322,5.051765e-7,0.0001641739,0.00001419044,0.0001841156,0.08485083],"study_design_scores_gemma":[0.190481,0.01333104,0.7915974,0.001851364,0.0009960518,0.000007406982,0.0000796093,0.0004582838,0.0002998144,0.00002674922,0.0007361363,0.0001351284],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839327,0.008528806,0.000115361,0.004567565,0.001154542,0.001567916,0.0000787656,0.00000608124,0.00004825355],"genre_scores_gemma":[0.9851302,0.01309497,0.0006233297,0.000459458,0.0005151124,0.0000929213,0.000007332165,0.0000218365,0.00005484116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08471569,"threshold_uncertainty_score":0.7654083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06979469026144287,"score_gpt":0.5023767545804756,"score_spread":0.4325820643190327,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}